spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  respiratory depression 

 HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 25 Jun 2021
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Devices Monitoring
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 Jun 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO(R) (Diazepam Nasal Spray)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Nov 2018
Indivior Announces Health Canada Approval of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 May 2018
ADAPT Pharma(R) Launches NARCANDirect.com
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 1 Mar 2018
SUBLOCADE(TM) (Buprenorphine Extended-Release) is Now Available as First and Only Monthly Injectable Buprenorphine in the U.S. to Treat Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Apr 2017
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond(TM) (oxycodone hydrochloride) tablets CII, the First and Only Immediate Release Opioid Analgesic with Abuse-Deterrent Label Claims
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
Devices Orthopaedic FDA
 HSMN NewsFeed - 6 Oct 2016
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Apr 2016
Study Shows Minute Ventilation Preferred Over End-Tidal CO(2) In Monitoring For Life-Threatening Opioid Induced Respiratory Depression
Devices Monitoring
 HSMN NewsFeed - 11 Apr 2016
Adapt Pharma Names Mike Kelly President of U.S. Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 12 Jan 2016
Former Philips Health Systems Corporate VP and Head of North American Business Transformation Joins Respiratory Motion as Chief Commercial Officer
Devices Monitoring Personnel
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Mar 2015
Mylan Launches Generic Antabuse(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Sep 2014
Yale-New Haven Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes
Devices Monitoring
 HSMN NewsFeed - 13 Sep 2013
Rochester General Health System Installs Masimo Patient SafetyNet(TM) for Advanced Care and Oversight of Patients
Devices Monitoring
 HSMN NewsFeed - 5 Jul 2013
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2013
New Clinical Study Finds Masimo rainbow(R) Acoustic Monitoring(TM) Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical Patients
Devices Monitoring
 HSMN NewsFeed - 28 Feb 2013
Pernix Therapeutics Receives FDA Approvals
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 12 Nov 2012
Trinity Medical Center Adds Masimo Patient SafetyNet(TM) as a High Vigilance Safeguard for Post-Surgical Patients
Devices Monitoring
 HSMN NewsFeed - 6 Nov 2012
Skagit Valley Hospital Standardizes on Masimo SET(R) Measure-Through Motion and Low Perfusion Pulse Oximetry
Devices Monitoring
 HSMN NewsFeed - 20 Aug 2012
Reckitt Benckiser Pharmaceuticals Inc. Announces FDA Approval of Two New Dosage Strengths of Suboxone(R) Sublingual Film (C-III) for Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 May 2012
First Published Study on Masimo Acoustic Respiration Rate Demonstrates Significantly Higher Patient Tolerance and Similar Accuracy Compared to Capnometry in Post-Surgical Patients
Devices Monitoring Surgery
 HSMN NewsFeed - 20 Mar 2012
Covidien Announces FDA 510(k) Clearance of Nellcor(TM) Respiration Rate Software
Devices Monitoring FDA
 HSMN NewsFeed - 22 Dec 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2011
ViroPharma's Buccolam(R) (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2010
Masimo Initiates Full Market Release of Rainbow Acoustic Monitoring
Devices Monitoring
 HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 19 Apr 2010
Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2009
Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring
Devices Monitoring FDA
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Sep 2009
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2009
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2009
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
Devices Monitoring
 HSMN NewsFeed - 14 May 2009
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2009
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2009
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
Devices Monitoring
 HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 23 Mar 2009
Covidien Receives FDA Clearance for the Nellcor OxiMax N-600x Pulse Oximeter with OxiMax SPD Alert
Devices Monitoring FDA
 HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 31 Dec 2008
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
Biopharmaceuticals Drug Delivery Product Recall
 HSMN NewsFeed - 14 Dec 2008
FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Dec 2008
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 2 Sep 2008
Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 2 Sep 2008
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 6 May 2008
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Cortex Receives Approval from German Regulatory Authority to Proceed with Two Clinical Trials for AMPAKINE(R) CX717 for the Acute Treatment of Respiratory Depression Due to Opiate Analgesics
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Mar 2008
Endo Pharmaceuticals to Launch Three New Dosage Strengths of OPANA(R) ER
Biopharmaceuticals Pain Management FDA
 HSMN NewsFeed - 15 Oct 2007
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Biopharmaceuticals Pain Mangement FDA
 HSMN NewsFeed - 10 Oct 2007
Anesiva Defines Regulatory Pathway for Adlea with FDA
Biopharmaceuticals Surgery
 HSMN NewsFeed - 3 Oct 2007
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
Pain Management Surgery
 HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Biopharmaceuticals
 HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Sep 2007
Cortex Files AMPAKINE CX717 IND for ADHD
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Aug 2007
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Aug 2007
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Aug 2007
Neuromed Appoints Mario Orlando as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2007
Labopharm and Paladin Complete Canadian Licensing and Distribution Agreement for Labopharm's Once-Daily Tramadol Product
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 18 Jun 2007
Labopharm's Once-Daily Tramadol Approved for Sale in Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jun 2007
Collegium Pharmaceutical Inc., Announces the Filing of IND for Abuse Deterrent Sustained Release Opioid Product
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 May 2007
Cortex and the University of Alberta Complete Patent License Agreement
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 1 May 2007
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 Apr 2007
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 2 Apr 2007
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 12 Mar 2007
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Mar 2007
FDA Approves Alpharma's KADIAN(R) New 200 Mg Strength
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Feb 2007
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Dec 2006
Beijing Med-Pharm Corporation Enters Into an Agreement to Develop and Register Products for Cephalon, Inc. in China
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2006
Cara Therapeutics Secures $19 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Oct 2006
Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin(R) Tablets Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2006
Anesiva Announces That FDA Grants Orphan Drug Status for Pain Drug 4975 to Treat Interdigital Neuroma
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Oct 2006
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Oct 2006
SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Oct 2006
UCB and Jazz Pharmaceuticals Announce Expansion of Xyrem(R) License Agreement to Include Fibromyalgia Syndrome
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Sep 2006
Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Oncology Drug Delivery FDA
 HSMN NewsFeed - 7 Sep 2006
Jazz Pharmaceuticals Announces Phase III Clinical Trial to Study the Safety and Efficacy of Xyrem(R) (Sodium Oxybate) in Patients With Fibromyalgia Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 29 Aug 2006
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Litigation
 HSMN NewsFeed - 17 Aug 2006
Endo Comments on Recent Announcement by Penwest Pharmaceuticals, Its Development Partner on Opana(R) ER
Biopharmaceuticals
 HSMN NewsFeed - 28 Jul 2006
European Union's CHMP Adopts Positive Opinion for SUBOXONE(R) (Buprenorphine/Naloxone) for Treatment of Opioid Dependence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jul 2006
Endo Announces Commercial Availability of Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate-Release Tablets CII
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2006
Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Jun 2006
Endo Receives FDA Approval for Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate Release Tablets CII
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jun 2006
Valeant Pharmaceuticals Receives FDA Approval of Zelapar(R) for Patients with Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 14 Jun 2006
Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries
Biopharmaceuticals Surgery
 HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2006
Oxymorphone Studies Presented at American Pain Society Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2006
Corgentech Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief of Pain and improved function in Elbow Tendonitis
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2006
SkyePharma Announces First European Approval of DepoDur(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Mar 2006
Xyrem(R) (Sodium Oxybate) Now Available for the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Narcolepsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Feb 2006
Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain in Patients With Fibromyalgia
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-based oxycodone) Receives Special Protocol Assessment and Commences Pivotal Phase III
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 30 Jan 2006
European Commission Approves IONSYS(TM) (Fentanyl HCl Iontophoretic Transdermal System)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 5 Jan 2006
OxyContin(R) Dismissals and Withdrawals Exceed 400
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Jan 2006
Cara Therapeutics Announces Global Licensing Deal of Novel Pain Drug Candidate With ALZA Corporation
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 42

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 42 additional stories matching:
respiratory depression
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.